{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:55:11Z","timestamp":1790283311929,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan University of Chinese Medicine 2023 annual postgraduate research and innovation ability improvement plan project","award":["2023KYCX050"],"award-info":[{"award-number":["2023KYCX050"]}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["No. 232102310153"],"award-info":[{"award-number":["No. 232102310153"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"he Natural Science Foundation of Henan Province","award":["No.242300420437"],"award-info":[{"award-number":["No.242300420437"]}]},{"name":"the Key Scientific Research project of Henan Higher Education Institutions","award":["No.24A310007"],"award-info":[{"award-number":["No.24A310007"]}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-03-27"],"award-info":[{"award-number":["320.6750.2024-03-27"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-024-02556-y","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T19:11:47Z","timestamp":1731006707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Characterization of phage HZY2308 against Acinetobacter baumannii and identification of phage-resistant bacteria"],"prefix":"10.1186","volume":"21","author":[{"given":"Ruilin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"2556_CR1","doi-asserted-by":"publisher","first-page":"1045206","DOI":"10.3389\/fmicb.2022.1045206","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Ding Y, Wei Y, Jian C, Liu J, Zeng Z. Carbapenem-resistant Acinetobacter baumannii: a challenge in the intensive care unit. Front Microbiol. 2022;13:1045206.","journal-title":"Front Microbiol"},{"key":"2556_CR2","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/v14061240","volume":"14","author":"M Mardiana","year":"2022","unstructured":"Mardiana M, Teh S-H, Lin L-C, Lin N-T. Isolation and characterization of a Novel Siphoviridae phage, vB_AbaS_TCUP2199, infecting Multidrug-Resistant Acinetobacter baumannii. Viruses. 2022;14:1240.","journal-title":"Viruses"},{"key":"2556_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.62347\/KBSB9946","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Chen Q-W, Qin Y-C, Yi X-L, Zeng H. Analysis of carbapenem-resistant Acinetobacter baumannii carbapenemase gene distribution and biofilm formation. Int J Mol Epidemiol Genet. 2024;15:1\u201311.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"2556_CR4","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1038\/s41598-024-54469-z","volume":"14","author":"N Bagi\u0144ska","year":"2024","unstructured":"Bagi\u0144ska N, Grygiel I, Orwat F, Harhala MA, J\u0119drusiak A, G\u0119barowska E, et al. Stability study in selected conditions and biofilm-reducing activity of phages active against drug-resistant Acinetobacter baumannii. Sci Rep. 2024;14:4285.","journal-title":"Sci Rep"},{"key":"2556_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.15324\/kjcls.2018.50.2.100","volume":"50","author":"JY Sung","year":"2018","unstructured":"Sung JY. Molecular characterization and Antimicrobial susceptibility of Biofilm-forming\u2009<\u2009italic\u2009>\u2009Acinetobacter baumannii Clinical isolates from Daejeon, Korea. Korean J Clin Lab Sci. 2018;50:100\u20139.","journal-title":"Korean J Clin Lab Sci"},{"key":"2556_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejmech.2017.03.022","volume":"131","author":"MI El-Gamal","year":"2017","unstructured":"El-Gamal MI, Brahim I, Hisham N, Aladdin R, Mohammed H, Bahaaeldin A. Recent updates of carbapenem antibiotics. Eur J Med Chem. 2017;131:185\u201395.","journal-title":"Eur J Med Chem"},{"key":"2556_CR7","doi-asserted-by":"crossref","unstructured":"Aggarwal R, Mahajan P, Pandiya S, Bajaj A, Verma SK, Yadav P et al. Antibiotic resistance: a global crisis, problems and solutions. Crit Rev Microbiol. 2024;50:1\u201326.","DOI":"10.1080\/1040841X.2024.2313024"},{"key":"2556_CR8","unstructured":"Tb DW, Ra N. B, P P, B L, B S. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev [Internet]. 2017 [cited 2024 Apr 18];30. https:\/\/pubmed.ncbi.nlm.nih.gov\/27974412\/"},{"key":"2556_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","volume":"19","author":"P Jault","year":"2019","unstructured":"Jault P, Leclerc T, Jennes S, Pirnay JP, Que Y-A, Resch G, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial. Lancet Infect Dis. 2019;19:35\u201345.","journal-title":"Lancet Infect Dis"},{"key":"2556_CR10","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","volume":"22","author":"S Uyttebroek","year":"2022","unstructured":"Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, et al. Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review. Lancet Infect Dis. 2022;22:e208\u201320.","journal-title":"Lancet Infect Dis"},{"key":"2556_CR11","unstructured":"Kasman LM, Porter LD. Bacteriophages. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Apr 17]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493185\/"},{"key":"2556_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrmicro1750","volume":"5","author":"CA Suttle","year":"2007","unstructured":"Suttle CA. Marine viruses\u2013major players in the global ecosystem. Nat Rev Microbiol. 2007;5:801\u201312.","journal-title":"Nat Rev Microbiol"},{"key":"2556_CR13","doi-asserted-by":"crossref","unstructured":"King AMQ, Adams MJ, Carstens EB, Lefkowitz EJ, editors. Order - Caudovirales. Virus taxonomy [Internet]. San Diego: Elsevier; 2012 [cited 2024 Apr 28]. pp. 39\u201345. https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978012384684600001X","DOI":"10.1016\/B978-0-12-384684-6.00001-X"},{"key":"2556_CR14","doi-asserted-by":"publisher","first-page":"e00353","DOI":"10.1128\/mSystems.00353-20","volume":"5","author":"A Luque","year":"2020","unstructured":"Luque A, Silveira CB. Quantification of Lysogeny caused by phage coinfections in Microbial communities from Biophysical principles. mSystems. 2020;5:e00353\u201320.","journal-title":"mSystems"},{"key":"2556_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-med-080219-122208","volume":"73","author":"GF Hatfull","year":"2022","unstructured":"Hatfull GF, Dedrick RM, Schooley RT. Phage therapy for antibiotic-resistant bacterial infections. Annu Rev Med. 2022;73:197\u2013211.","journal-title":"Annu Rev Med"},{"key":"2556_CR16","unstructured":"G\u00f3rski M\u0141KD. A. Engineered Bacteriophage Therapeutics: rationale, challenges and future. BioDrugs Clin Immunotherapeutics Biopharmaceuticals Gene Therapy [Internet]. 2021 [cited 2023 Jan 16];35. https:\/\/pubmed.ncbi.nlm.nih.gov\/33881767\/"},{"key":"2556_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee SA, Hatfull GF, Mutalik VK, Schooley RT. Phage therapy: from biological mechanisms to future directions. Cell. 2023;186:17\u201331.","journal-title":"Cell"},{"key":"2556_CR18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/antibiotics9060291","volume":"9","author":"E Laanto","year":"2020","unstructured":"Laanto E, M\u00e4kel\u00e4 K, Hoikkala V, Ravantti JJ, Sundberg L-R. Adapting a phage to combat phage resistance. Antibiot (Basel). 2020;9:291.","journal-title":"Antibiot (Basel)"},{"key":"2556_CR19","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41579-023-00934-x","volume":"21","author":"H Georjon","year":"2023","unstructured":"Georjon H, Bernheim A. The highly diverse antiphage defence systems of bacteria. Nat Rev Microbiol. 2023;21:686\u2013700.","journal-title":"Nat Rev Microbiol"},{"key":"2556_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","volume":"8","author":"SJ Labrie","year":"2010","unstructured":"Labrie SJ, Samson JE, Moineau S. Bacteriophage resistance mechanisms. Nat Rev Microbiol. 2010;8:317\u201327.","journal-title":"Nat Rev Microbiol"},{"key":"2556_CR21","doi-asserted-by":"publisher","first-page":"1173894","DOI":"10.3389\/fcimb.2023.1173894","volume":"13","author":"T Nayak","year":"2023","unstructured":"Nayak T, Kakkar A, Singh RK, Jaiswal LK, Singh AK, Temple L, et al. Isolation and characterization of a novel mycobacteriophage Kashi-VT1 infecting Mycobacterium species. Front Cell Infect Microbiol. 2023;13:1173894.","journal-title":"Front Cell Infect Microbiol"},{"key":"2556_CR22","doi-asserted-by":"publisher","first-page":"199184","DOI":"10.1016\/j.virusres.2023.199184","volume":"335","author":"B Fei","year":"2023","unstructured":"Fei B, Li D, Liu X, You X, Guo M, Ren Y, et al. Characterization and genomic analysis of a broad-spectrum lytic phage HZ2201 and its antibiofilm efficacy against Pseudomonas aeruginosa. Virus Res. 2023;335:199184.","journal-title":"Virus Res"},{"key":"2556_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/v14071490","volume":"14","author":"T Glonti","year":"2022","unstructured":"Glonti T, Pirnay J-P. In Vitro techniques and measurements of phage characteristics that are important for phage therapy success. Viruses. 2022;14:1490.","journal-title":"Viruses"},{"key":"2556_CR24","doi-asserted-by":"publisher","first-page":"e0118557","DOI":"10.1371\/journal.pone.0118557","volume":"10","author":"M Khan Mirzaei","year":"2015","unstructured":"Khan Mirzaei M, Nilsson AS. Isolation of phages for phage therapy: a comparison of Spot tests and efficiency of plating analyses for determination of host range and efficacy. PLoS ONE. 2015;10:e0118557.","journal-title":"PLoS ONE"},{"key":"2556_CR25","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/antibiotics11091175","volume":"11","author":"AJK Coyne","year":"2022","unstructured":"Coyne AJK, Stamper K, Kebriaei R, Holger DJ, El Ghali A, Morrisette T, et al. Phage cocktails with Daptomycin and Ampicillin eradicates Biofilm-embedded multidrug-resistant Enterococcus faecium with preserved phage susceptibility. Antibiot (Basel). 2022;11:1175.","journal-title":"Antibiot (Basel)"},{"key":"2556_CR26","doi-asserted-by":"crossref","unstructured":"Kunz Coyne AJ, Stamper K, Bleick C, Kebriaei R, Lehman SM, Rybak MJ. Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms. Microbiol Spectr. 2024;12:e03212\u201323.","DOI":"10.1128\/spectrum.03212-23"},{"key":"2556_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/ph17020155","volume":"17","author":"R Soontarach","year":"2024","unstructured":"Soontarach R, Srimanote P, Voravuthikunchai SP, Chusri S. Antibacterial and Anti-biofilm Efficacy of Endolysin LysAB1245 against a panel of important pathogens. Pharmaceuticals (Basel). 2024;17:155.","journal-title":"Pharmaceuticals (Basel)"},{"key":"2556_CR28","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/molecules24101849","volume":"24","author":"C-H Yang","year":"2019","unstructured":"Yang C-H, Su P-W, Moi S-H, Chuang L-Y. Biofilm formation in Acinetobacter Baumannii: genotype-phenotype correlation. Molecules. 2019;24:1849.","journal-title":"Molecules"},{"key":"2556_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/antibiotics9110817","volume":"9","author":"AM Shenkutie","year":"2020","unstructured":"Shenkutie AM, Yao MZ, Siu GK, Wong BKC, Leung PH. Biofilm-induced antibiotic resistance in clinical Acinetobacter baumannii isolates. Antibiot (Basel). 2020;9:817.","journal-title":"Antibiot (Basel)"},{"key":"2556_CR30","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3390\/microorganisms9112365","volume":"9","author":"MAF Khalil","year":"2021","unstructured":"Khalil MAF, Ahmed FA, Elkhateeb AF, Mahmoud EE, Ahmed MI, Ahmed RI, et al. Virulence characteristics of biofilm-forming Acinetobacter baumannii in clinical isolates using a Galleria mellonella model. Microorganisms. 2021;9:2365.","journal-title":"Microorganisms"},{"key":"2556_CR31","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.3390\/jcm12165168","volume":"12","author":"G Granata","year":"2023","unstructured":"Granata G, Taglietti F, Petrosillo N. Tackling Acinetobacter baumannii. J Clin Med. 2023;12:5168.","journal-title":"J Clin Med"},{"key":"2556_CR32","doi-asserted-by":"publisher","first-page":"e00310","DOI":"10.1128\/mSphere.00310-16","volume":"2","author":"A Giammanco","year":"2017","unstructured":"Giammanco A, Cal\u00e0 C, Fasciana T, Dowzicky MJ. Global Assessment of the activity of Tigecycline against Multidrug-Resistant Gram-negative pathogens between 2004 and 2014 as part of the Tigecycline evaluation and Surveillance Trial. mSphere. 2017;2:e00310\u201316.","journal-title":"mSphere"},{"key":"2556_CR33","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1007\/s11033-021-06690-6","volume":"48","author":"S Ibrahim","year":"2021","unstructured":"Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021;48:6987\u201398.","journal-title":"Mol Biol Rep"},{"key":"2556_CR34","unstructured":"Rt S, Jj BB, A H-M G et al. J L, L L,. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrobial Agents Chemotherapy [Internet]. 2017 [cited 2023 Jan 16];61. https:\/\/pubmed.ncbi.nlm.nih.gov\/28807909\/"},{"key":"2556_CR35","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1080\/22221751.2021.1902754","volume":"10","author":"N Wu","year":"2021","unstructured":"Wu N, Dai J, Guo M, Li J, Zhou X, Li F, et al. Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients. Emerg Microbes Infect. 2021;10:612\u20138.","journal-title":"Emerg Microbes Infect"},{"key":"2556_CR36","doi-asserted-by":"crossref","unstructured":"Rao S, Betancourt-Garcia M, Kare-Opaneye YO, Swierczewski BE, Bennett JW, Horne B et al. Critically ill patient with multidrug-resistant Acinetobacter baumannii respiratory infection successfully treated with intravenous and nebulized bacteriophage therapy. Antimicrob Agents Chemother. 2022;66:e00824\u201321.","DOI":"10.1128\/AAC.00824-21"},{"key":"2556_CR37","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/cid\/ciz222","volume":"69","author":"R Nir-Paz","year":"2019","unstructured":"Nir-Paz R, Gelman D, Khouri A, Sisson BM, Fackler J, Alkalay-Oren S, et al. Successful treatment of Antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics Combination. Clin Infect Dis. 2019;69:2015\u20138.","journal-title":"Clin Infect Dis"},{"key":"2556_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/jctb.4245","volume":"89","author":"EJ Vandamme","year":"2014","unstructured":"Vandamme EJ. Phage therapy and phage control: to be revisited urgently!! J Chem Technol Biotechnol. 2014;89:329\u201333.","journal-title":"J Chem Technol Biotechnol"},{"key":"2556_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/jam.13134","volume":"121","author":"J Jeon","year":"2016","unstructured":"Jeon J, D\u2019Souza R, Pinto N, Ryu C-M, Park J, Yong D, et al. Characterization and complete genome sequence analysis of two myoviral bacteriophages infecting clinical carbapenem-resistant Acinetobacter baumannii isolates. J Appl Microbiol. 2016;121:68\u201377.","journal-title":"J Appl Microbiol"},{"key":"2556_CR40","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.2147\/IDR.S307494","volume":"14","author":"A Hussain","year":"2021","unstructured":"Hussain A, Kousar S, Ullah I, Zulfiqar A, Ali HA, Manzoor A, et al. Investigations on Acinetophage, QAB 3.4, Targeting extensively drug-resistant Acinetobacter baumannii isolates. Infect Drug Resist. 2021;14:4261\u20139.","journal-title":"Infect Drug Resist"},{"key":"2556_CR41","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3390\/v15081665","volume":"15","author":"AG Cobi\u00e1n G\u00fcemes","year":"2023","unstructured":"Cobi\u00e1n G\u00fcemes AG, Le T, Rojas MI, Jacobson NE, Villela H, McNair K, et al. Compounding Achromobacter phages for therapeutic applications. Viruses. 2023;15:1665.","journal-title":"Viruses"},{"key":"2556_CR42","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/jcp.30683","volume":"237","author":"V Kaushik","year":"2022","unstructured":"Kaushik V, Tiwari M, Joshi R, Tiwari V. Therapeutic strategies against potential antibiofilm targets of multidrug-resistant Acinetobacter baumannii. J Cell Physiol. 2022;237:2045\u201363.","journal-title":"J Cell Physiol"},{"key":"2556_CR43","doi-asserted-by":"crossref","unstructured":"Bhartiya SK, Prasad R, Sharma S, Shukla V, Nath G, Kumar R. Biological therapy on infected traumatic wounds: a case-control study. Int J Low Extrem Wounds. 2022;15347346211072779.","DOI":"10.1177\/15347346211072779"},{"key":"2556_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/pr400603f","volume":"13","author":"CM Gayoso","year":"2014","unstructured":"Gayoso CM, Mateos J, M\u00e9ndez JA, Fern\u00e1ndez-Puente P, Rumbo C, Tom\u00e1s M, et al. Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii. J Proteome Res. 2014;13:460\u201376.","journal-title":"J Proteome Res"},{"key":"2556_CR45","doi-asserted-by":"crossref","unstructured":"Tang Z, Li X, Wang X, Zhang C, Zou L, Ren H et al. Characterization and genomic analysis of a novel lytic phage DCp1 against Clostridium perfringens biofilms. Int J Mol Sci [Internet]. 2023 [cited 2024 May 6];24. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9965233\/","DOI":"10.3390\/ijms24044191"},{"key":"2556_CR46","doi-asserted-by":"crossref","unstructured":"Ding Y, Huang C, Zhu W, Li Z, Zhang Y, Wang J, Pan H, Li H, Wang X, Characterization of a novel Jerseyvirus phage T102 and its inhibition effect on biofilms of multidrug-resistant Salmonella. Virus research [Internet]. 2023 [cited 2024 May 6];326. https:\/\/pubmed.ncbi.nlm.nih.gov\/36717022\/","DOI":"10.1016\/j.virusres.2023.199054"},{"key":"2556_CR47","doi-asserted-by":"crossref","unstructured":"Jiang L, Xu Q, Wu Y, Zhou X, Chen Z, Sun Q et al. Characterization of a Straboviridae phage vB_AbaM-SHI and its inhibition effect on biofilms of Acinetobacter baumannii. Front Cell Infect Microbiol [Internet]. 2024 [cited 2024 Apr 17];14. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10958429\/","DOI":"10.3389\/fcimb.2024.1351993"},{"key":"2556_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10930-023-10139-z","volume":"42","author":"B Liu","year":"2023","unstructured":"Liu B, Guo Q, Li Z, Guo X, Liu X. Bacteriophage endolysin: a powerful weapon to control bacterial biofilms. Protein J. 2023;42:463\u201376.","journal-title":"Protein J"},{"key":"2556_CR49","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1111\/1541-4337.12757","volume":"20","author":"Z Huang","year":"2021","unstructured":"Huang Z, Zhang Z, Tong J, Malakar PK, Chen L, Liu H, et al. Phages and their lysins: toolkits in the battle against foodborne pathogens in the postantibiotic era. Compr Rev Food Sci Food Saf. 2021;20:3319\u201343.","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"2556_CR50","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3390\/antibiotics10111277","volume":"10","author":"MU Rahman","year":"2021","unstructured":"Rahman MU, Wang W, Sun Q, Shah JA, Li C, Sun Y, et al. Endolysin, a Promising solution against Antimicrobial Resistance. Antibiot (Basel). 2021;10:1277.","journal-title":"Antibiot (Basel)"},{"key":"2556_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/1751-7915.13594","volume":"14","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Li X, Wang L, Li G, Cong C, Li R, et al. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity. Microb Biotechnol. 2020;14:403\u201318.","journal-title":"Microb Biotechnol"},{"key":"2556_CR52","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11274-024-03999-9","volume":"40","author":"AM Lendel","year":"2024","unstructured":"Lendel AM, Antonova NP, Grigoriev IV, Usachev EV, Gushchin VA, Vasina DV. Biofilm-disrupting effects of phage endolysins LysAm24, LysAp22, LysECD7, and LysSi3: breakdown the matrix. World J Microbiol Biotechnol. 2024;40:186.","journal-title":"World J Microbiol Biotechnol"},{"key":"2556_CR53","doi-asserted-by":"publisher","first-page":"183771","DOI":"10.1016\/j.bbamem.2021.183771","volume":"1863","author":"T Ahammad","year":"2021","unstructured":"Ahammad T, Khan RH, Sahu ID, Drew DL, Faul E, Li T, et al. Pinholin S21 mutations induce structural topology and conformational changes. Biochim Biophys Acta Biomembr. 2021;1863:183771.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"2556_CR54","doi-asserted-by":"crossref","unstructured":"Xiang Y, Wang S, Huang H, Li X, Li H, Tu Y, Wei Y, Song F, Ji X, A novel holin from an Enterococcus faecalis phage and application in vitro and in vivo. Microbial pathogenesis [Internet]. 2024 [cited 2024 May 6];186. https:\/\/pubmed.ncbi.nlm.nih.gov\/38048838\/","DOI":"10.1016\/j.micpath.2023.106471"},{"key":"2556_CR55","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40121-022-00597-w","volume":"11","author":"C Bartal","year":"2022","unstructured":"Bartal C, Rolston KVI, Nesher L. Carbapenem-resistant Acinetobacter baumannii: colonization, infection and current treatment options. Infect Dis Ther. 2022;11:683\u201394.","journal-title":"Infect Dis Ther"},{"key":"2556_CR56","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1093\/jac\/dkz337","volume":"74","author":"H Mei","year":"2019","unstructured":"Mei H, Yang T, Wang J, Wang R, Cai Y. Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis. J Antimicrob Chemother. 2019;74:3423\u201331.","journal-title":"J Antimicrob Chemother"},{"key":"2556_CR57","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/cid\/civ048","volume":"60","author":"ZA Qureshi","year":"2015","unstructured":"Qureshi ZA, Hittle LE, O\u2019Hara JA, Rivera JI, Syed A, Shields RK, et al. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis. 2015;60:1295\u2013303.","journal-title":"Clin Infect Dis"},{"key":"2556_CR58","doi-asserted-by":"publisher","first-page":"14140","DOI":"10.1038\/s41598-018-32344-y","volume":"8","author":"M Jansen","year":"2018","unstructured":"Jansen M, Wahida A, Latz S, Kr\u00fcttgen A, H\u00e4fner H, Buhl EM, et al. Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii. Sci Rep. 2018;8:14140.","journal-title":"Sci Rep"},{"key":"2556_CR59","doi-asserted-by":"publisher","first-page":"631585","DOI":"10.3389\/fcimb.2021.631585","volume":"11","author":"X Tan","year":"2021","unstructured":"Tan X, Chen H, Zhang M, Zhao Y, Jiang Y, Liu X, et al. Clinical experience of personalized phage therapy against Carbapenem-Resistant Acinetobacter baumannii Lung infection in a patient with Chronic Obstructive Pulmonary Disease. Front Cell Infect Microbiol. 2021;11:631585.","journal-title":"Front Cell Infect Microbiol"},{"key":"2556_CR60","doi-asserted-by":"publisher","first-page":"784949","DOI":"10.3389\/fmicb.2021.784949","volume":"12","author":"A Ambroa","year":"2022","unstructured":"Ambroa A, Blasco L, L\u00f3pez M, Pacios O, Bleriot I, Fern\u00e1ndez-Garc\u00eda L, et al. Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to phage infection. Front Microbiol. 2022;12:784949.","journal-title":"Front Microbiol"},{"key":"2556_CR61","doi-asserted-by":"publisher","first-page":"102240","DOI":"10.1016\/j.mib.2022.102240","volume":"71","author":"J Klumpp","year":"2023","unstructured":"Klumpp J, Dunne M, Loessner MJ. A perfect fit: bacteriophage receptor-binding proteins for diagnostic and therapeutic applications. Curr Opin Microbiol. 2023;71:102240.","journal-title":"Curr Opin Microbiol"},{"key":"2556_CR62","doi-asserted-by":"publisher","first-page":"fuab048","DOI":"10.1093\/femsre\/fuab048","volume":"46","author":"JE Egido","year":"2021","unstructured":"Egido JE, Costa AR, Aparicio-Maldonado C, Haas P-J, Brouns SJJ. Mechanisms and clinical importance of bacteriophage resistance. FEMS Microbiol Rev. 2021;46:fuab048.","journal-title":"FEMS Microbiol Rev"},{"key":"2556_CR63","doi-asserted-by":"publisher","first-page":"e0363122","DOI":"10.1128\/spectrum.03631-22","volume":"11","author":"OY Timoshina","year":"2023","unstructured":"Timoshina OY, Kasimova AA, Shneider MM, Arbatsky NP, Shashkov AS, Shelenkov AA, et al. Loss of a Branch Sugar in the Acinetobacter baumannii K3-Type capsular polysaccharide due to frameshifts in the gtr6 glycosyltransferase gene leads to susceptibility to phage APK37.1. Microbiol Spectr. 2023;11:e0363122.","journal-title":"Microbiol Spectr"},{"key":"2556_CR64","doi-asserted-by":"publisher","first-page":"e0150321","DOI":"10.1128\/spectrum.01503-21","volume":"10","author":"NP Arbatsky","year":"2022","unstructured":"Arbatsky NP, Kasimova AA, Shashkov AS, Shneider MM, Popova AV, Shagin DA, et al. Involvement of a phage-encoded wzy protein in the polymerization of K127 units to form the Capsular Polysaccharide of Acinetobacter baumannii isolate 36-1454. Microbiol Spectr. 2022;10:e0150321.","journal-title":"Microbiol Spectr"},{"key":"2556_CR65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41564-020-00830-7","volume":"6","author":"F Gordillo Altamirano","year":"2021","unstructured":"Gordillo Altamirano F, Forsyth JH, Patwa R, Kostoulias X, Trim M, Subedi D, et al. Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials. Nat Microbiol. 2021;6:157\u201361.","journal-title":"Nat Microbiol"},{"key":"2556_CR66","doi-asserted-by":"publisher","first-page":"e62160","DOI":"10.1371\/journal.pone.0062160","volume":"8","author":"JJ Kenyon","year":"2013","unstructured":"Kenyon JJ, Hall RM. Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes. PLoS ONE. 2013;8:e62160.","journal-title":"PLoS ONE"},{"key":"2556_CR67","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1080\/22221751.2021.2002671","volume":"10","author":"X Wang","year":"2021","unstructured":"Wang X, Loh B, Gordillo Altamirano F, Yu Y, Hua X, Leptihn S. Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture. Emerg Microbes Infect. 2021;10:2205\u201319.","journal-title":"Emerg Microbes Infect"},{"key":"2556_CR68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/phar.2358","volume":"40","author":"T Morrisette","year":"2020","unstructured":"Morrisette T, Kebriaei R, Lev KL, Morales S, Rybak MJ. Bacteriophage therapeutics: a primer for clinicians on phage-antibiotic combinations. Pharmacotherapy. 2020;40:153\u201368.","journal-title":"Pharmacotherapy"},{"key":"2556_CR69","doi-asserted-by":"publisher","first-page":"26717","DOI":"10.1038\/srep26717","volume":"6","author":"BK Chan","year":"2016","unstructured":"Chan BK, Sistrom M, Wertz JE, Kortright KE, Narayan D, Turner PE. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci Rep. 2016;6:26717.","journal-title":"Sci Rep"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02556-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T20:01:43Z","timestamp":1731009703000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2556"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02556-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"22 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}